hDcp2 activators are a specialized class of chemical compounds that are designed to enhance the functional activity of the human mRNA-decapping enzyme Dcp2, which is encoded by the gene NUDT16. This enzyme plays a crucial role in the regulation of mRNA degradation, a fundamental process in the post-transcriptional control of gene expression. By removing the 5' cap structure of mRNA, hDcp2 marks the transcript for degradation, thus influencing mRNA turnover and, as a result, affecting the levels of protein synthesis within the cell. The activators of hDcp2 function by stabilizing the enzyme, enhancing its affinity for the mRNA cap structure, or by facilitating the catalytic activity required for cap hydrolysis. Some compounds may mimic the natural substrates or cofactors of the enzyme, thus promoting its activity, while others could bind to allosteric sites, inducing conformational changes that lead to increased catalytic efficiency. These chemical activators are not merely indirect enhancers of general metabolic pathways but are specific to the mechanism of action of hDcp2, ensuring the precise regulation of gene expression through mRNA stability.
The biochemical activation mechanisms employed by hDcp2 activators are diverse and intricate. Certain activators may interact directly with the active site of the enzyme, promoting the decapping reaction. This can result in an accelerated turnover of mRNAs, effectively modulating gene expression patterns in response to cellular cues. Others might work by altering the interaction between hDcp2 and its coactivators or regulatory proteins, which can modulate the enzyme's activity indirectly. For instance, some molecules could disrupt inhibitory interactions, allowing hDcp2 to access its substrates more readily, or they could facilitate the formation of the hDcp2 complex with other proteins involved in mRNA decapping, such as hDcp1, enhancing the overall decapping activity. Importantly, these activators do not necessarily increase the expression of the NUDT16 gene or the abundance of the hDcp2 protein; rather, they augment the enzyme's functional activity through chemical interactions at the molecular level. This nuanced mode of action positions hDcp2 activators as tools for dissecting the complex regulatory networks that govern mRNA stability and gene expression.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $76.00 $150.00 $725.00 $1385.00 $2050.00 | 73 | |
Forskolin increases intracellular cAMP levels, which in turn activates PKA. PKA phosphorylation can enhance the activity of hDcp2 by promoting cellular processes that are conducive to mRNA decapping. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $76.00 $265.00 | 80 | |
Ionomycin acts as a calcium ionophore, increasing intracellular calcium levels. Elevated calcium can activate calmodulin-dependent kinase, which may enhance hDcp2 activity by influencing the decapping machinery. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $40.00 $129.00 $210.00 $490.00 $929.00 | 119 | |
Phorbol 12-myristate 13-acetate (PMA) activates protein kinase C (PKC). PKC has been implicated in the regulation of decapping through phosphorylation events that might enhance hDcp2 activity. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $285.00 $520.00 $1300.00 | 78 | |
Okadaic Acid is a potent inhibitor of protein phosphatases PP1 and PP2A, leading to increased phosphorylation levels of cellular proteins, which could enhance hDcp2 activity by modulating proteins interacting with the decapping complex. | ||||||
Rolipram | 61413-54-5 | sc-3563 sc-3563A | 5 mg 50 mg | $75.00 $212.00 | 18 | |
Rolipram inhibits phosphodiesterase 4 (PDE4), leading to an increase in cAMP levels, which can activate PKA and subsequently might enhance hDcp2 activity via phosphorylation of associated decapping proteins. | ||||||
Calyculin A | 101932-71-2 | sc-24000 sc-24000A sc-24000B sc-24000C | 10 µg 100 µg 500 µg 1 mg | $160.00 $750.00 $1400.00 $3000.00 | 59 | |
Calyculin A is an inhibitor of PP1 and PP2A like Okadaic Acid, and it can increase phosphorylation within the cell, potentially enhancing hDcp2 activity by altering the phosphorylation status of proteins that regulate mRNA decapping. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $42.00 $72.00 $124.00 $238.00 $520.00 $1234.00 | 11 | |
EGCG is a catechin found in green tea with kinase inhibitory activity. It could enhance hDcp2 function by inhibiting kinases that negatively regulate the decapping machinery. | ||||||
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $150.00 $388.00 | 113 | |
Staurosporine is a broad-spectrum protein kinase inhibitor; it may selectively enhance hDcp2 activity by inhibiting kinases that compete with or negatively regulate hDcp2's role in mRNA decapping. | ||||||
D-erythro-Sphingosine-1-phosphate | 26993-30-6 | sc-201383 sc-201383D sc-201383A sc-201383B sc-201383C | 1 mg 2 mg 5 mg 10 mg 25 mg | $162.00 $316.00 $559.00 $889.00 $1693.00 | 7 | |
Sphingosine-1-phosphate can activate sphingosine kinase, potentially influencing signaling pathways that converge on the mRNA decapping process, indirectly enhancing hDcp2 function. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $97.00 $254.00 | 36 | |
Anisomycin is a protein synthesis inhibitor that activates stress-activated protein kinases. This activation may indirectly enhance hDcp2 activity by affecting pathways that control mRNA stability and turnover. | ||||||